Treatment of Children and Adolescents With Stage II Testicular and Stages I and II Ovarian Malignant Germ Cell Tumors: A Pediatric Intergroup Study—Pediatric Oncology Group 9048 and Children's Cancer Group 8891
Journal of Clinical Oncology2004Vol. 22(17), pp. 3563–3569
Citations Over TimeTop 10% of 2004 papers
Paul Rogers, Thomas A. Olson, John W. Cullen, Deborah F. Billmire, Neyssa Marina, Frederick J. Rescorla, Mary M. Davis, Wendy B. London, Stephen J. Lauer, Roger Giller, Barbara Cushing
Abstract
Combination chemotherapy with PEB results in excellent EFS and OS with minimal toxicity in children and adolescents with localized gonadal MGCT.
Related Papers
- → Are 3 Cycles of Bleomycin, Etoposide and Cisplatin or 4 Cycles of Etoposide and Cisplatin Equivalent Optimal Regimens for Patients with Good Risk Metastatic Germ Cell Tumors of the Testis? The Need for A Randomized Trial(1997)17 cited
- → Response to high‐dose cisplatin and etoposide in advanced germ cell tumors in children: Results of the Brazilian germ cell tumor study(1995)9 cited
- → Liver metastases in germ cell tumors.(2017)1 cited
- → Are 3 Cycles of Bleomycin, Etoposide and Cisplatin or 4 Cycles of Etoposide and Cisplatin Equivalent Optimal Regimens for Patients with Good Risk Metastatic Germ Cell Tumors of the Testis? The Need for A Randomized Trial(1997)1 cited
- → Randomized Trial of Bleomycin, Etoposide, and Cisplatin Compared With Bleomycin, Etoposide, and Carboplatin in Good-Prognosis Metastatic Nonseminomatous Germ Cell Cancer(1998)